Q1 2022 Atea Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to the Atea Pharmaceuticals First Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's call is being recorded. I will now turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals. Thank you. You may begin.
Good morning, everyone, and welcome to Atea Pharmaceuticals First Quarter 2022 Financial Results Conference Call. This morning, we issued a press release which outlines the topics we plan to discuss, including newly released data for bemnifosbuvir for the treatment of COVID-19. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at ir.ateapharma.com.
With me today from Atea are Chief Executive Officer and Founder; Dr. Jean-Pierre Sommadossi; Chief Development Officer, Dr. Janet Hammond; Chief Financial Officer and Executive Vice President of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |